Abstract
Background
Obesity-associated systemic hypertension (HTN) and obstructive sleep apnea (OSA) have multiple pathophysiological pathways including ectopic fat deposition, inflammation, altered adipokine profile, and increased sympathetic nervous activity. We characterized these potential mechanisms in severely obese patients with or without HTN and OSA. We also compared changes of these mechanisms at 12 months following biliopancreatic diversion with duodenal switch (BPD-DS) surgery according to HTN and OSA resolution.
Methods
Sixty-two severely obese patients were evaluated at baseline and 12 months; 40 patients underwent BPD-DS. Blood samples, bioelectrical impedance analysis, computed tomography scan, and 24-h heart rate monitoring were performed. OSA have been determined with polysomnography and HTN with blood pressure measurement and medical file.
Results
Patients with HTN (n = 35) and OSA (n = 32) were older men with higher ectopic fat deposition and lower parasympathetic nervous activity without difference in adipokines and inflammatory markers. Lower reduction in weight was observed in patients with unresolved HTN (−40.9 ± 3.3 kg vs. −55.6 ± 3.8 kg; p = 0.001) and OSA (−41.4 ± 10.7 kg vs. −51.0 ± 15.2 kg; p = 0.006). Visceral adipose tissue reduction was lower in patients with unresolved HTN (−171.0 ± 25.7 cm2 vs. −274.5 ± 29.0 cm2; p = 0.001) in contrast to a trend for lower abdominal subcutaneous adipose tissue reduction in patients with unresolved OSA (−247.7 ± 91.5 cm2 vs. −390.5 ± 109.1 cm2; p = 0.08). At 12 months, parasympathetic activity was lowest in unresolved HTN and OSA patients, without difference in adipokines and inflammatory biomarkers.
Conclusion
Lower ectopic fat mobilization, lower level of parasympathetic nervous activity, and lower subcutaneous adiposity mobilization may play a role in the pathophysiology of unresolved HTN and OSA following BPD-DS surgery.
Similar content being viewed by others
References
Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701.
Hatoum IJ, Blackstone R, Hunter TD, et al. Clinical factors associated with remission of obesity-related comorbidities after bariatric surgery. JAMA Surg. 2015;14:1–8.
Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.
Dopp JM, Reichmuth KJ, Morgan BJ. Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management. Curr Hypertens Rep. 2007;9(6):529–34.
Dixon JB, Schachter LM, O'Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.
Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898–918.
Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301–13.
Yiannikouris F, Gupte M, Putnam K, et al. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens. 2010;19(2):195–200.
Li A, Nattie E. Orexin, cardio-respiratory function, and hypertension. Front Neurosci. 2014;8:22.
Ayada C, Toru U, Korkut Y. Nesfatin-1 and its effects on different systems. Hippokratia. 2015;19(1):4–10.
Kobat MA, Celik A, Balin M, et al. The investigation of serum vaspin level in atherosclerotic coronary artery disease. J Clin Med Res. 2012;4(2):110–3.
Neves KB, Nguyen Dinh Cat A, Lopes RA, et al. Chemerin regulates crosstalk between adipocytes and vascular cells through Nox. Hypertension. 2015;66(3):657–66.
Moreno-Navarrete JM, Ortega F, Castro A, et al. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity. 2011;19(8):1552–9.
Eckert DJ, Malhotra A. Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):144–53.
Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139(9):761–76.
Piche ME, Auclair A, Harvey J, et al. How to choose and use bariatric surgery in 2015. Can J Cardiol. 2015;31(2):153–66.
Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–6. discussion 7–8
Flores L, Vidal J, Canivell S, et al. Hypertension remission 1 year after bariatric surgery: predictive factors. Surg Obes Relat Dis. 2014;10(4):661–5.
Sarkhosh K, Switzer NJ, El-Hadi M, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23(3):414–23.
Ashrafian H, Toma T, Rowland SP, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015;25(7):1239–50.
Auclair A, Martin J, Bastien M, et al. Is there a role for visceral adiposity in inducing type 2 diabetes remission in severely obese patients following biliopancreatic diversion with duodenal switch surgery? Obes Surg. 2016;26(8):1717–27.
Martin J, Bergeron S, Pibarot P, et al. Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function. Can J Cardiol. 2013;29(8):969–75.
Epstein LJ, Kristo D, Strollo Jr PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–76.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999 8/1/1999;22(5):667–89.
Martin J, Smith J, Bastien M, et al. Comparison between arterial and venous sampling of circulating hormones, substrates and peptides in severe obesity. Clin Invest Med. 2011;34(2):E82–7.
Gupta A, Miegueu P, Lapointe M, et al. Acute post-bariatric surgery increase in orexin levels associates with preferential lipid profile improvement. PLoS One. 2014;9(1):e84803.
Lu H, Fouejeu Wamba PC, Lapointe M, et al. Increased vaspin levels are associated with beneficial metabolic outcome pre- and post-bariatric surgery. PLoS One. 2014;9(10):e111002.
St-Pierre DH, Martin J, Shimizu H, et al. Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch. Peptides. 2016;86:6–12.
Parlee SD, Wang Y, Poirier P, et al. Biliopancreatic diversion with duodenal switch modifies plasma chemerin in early and late post-operative periods. Obesity. 2015;23(6):1201–8.
Lapointe M, Poirier P, Martin J, et al. Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease. Cardiovasc Diabetol. 2014;13:124.
Smith JD, Cianflone K, Martin J, et al. Plasma adipokine and hormone changes in mountaineers on ascent to 5300 meters. Wilderness Environ Med. 2011;22(2):107–14.
Martin J, Paquette C, Marceau S, et al. Impact of orlistat-induced weight loss on diastolic function and heart rate variability in severely obese subjects with diabetes. J Obes. 2011;2011:394658.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17(3):354–81.
Bunag RD, Page IH, McCubbin JW. Neural stimulation of release of renin. Circ Res. 1966;19(4):851–8.
Cockcroft JR, Wilkinson IB, Webb DJ. The Trevor Howell lecture. Age, arterial stiffness and the endothelium. Age Ageing. 1997;26(Suppl 4):53–60.
Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203–10.
Reisin E, Frohlich ED, Messerli FH, et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98(3):315–9.
Benaiges D, Sague M, Flores-Le Roux JA, et al. Predictors of hypertension remission and recurrence after bariatric surgery. Am J Hypertens. 2016;29(5):653–9.
Arner P, Backdahl J, Hemmingsson P, et al. Regional variations in the relationship between arterial stiffness and adipocyte volume or number in obese subjects. Int J Obes. 2015;39(2):222–7.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
Ashrafian H, le Roux CW, Rowland SP, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures. Thorax. 2012;67(5):442–9.
Simpson L, Mukherjee S, Cooper MN, et al. Sex differences in the association of regional fat distribution with the severity of obstructive sleep apnea. Sleep. 2010;33(4):467–74.
Cowan DC, Livingston E. Obstructive sleep apnoea syndrome and weight loss: review. Sleep Disord. 2012;2012:163296.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the Fondation Institut universitaire de cardiologie et de pneumologie de Québec. Funding support granted to P.P.
Conflict of Interest
S.M. has a financial relationship from Medtronic and Johnson & Johnson. The other authors (A.A., L.B., F.-S.H., S.B., S.L., F.J., O.L., Y.L., M.-E.P., K.C., S.D.P., K.G., J.M., M.B., D.H.S.-P., and P.P.) declare that they have no conflict of interest.
Ethical Approval Statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent Statement
Informed consent was obtained from all individual participant included in the study.
Electronic supplementary material
ESM 1
(DOCX 29.8 kb)
Rights and permissions
About this article
Cite this article
Auclair, A., Biertho, L., Marceau, S. et al. Bariatric Surgery-Induced Resolution of Hypertension and Obstructive Sleep Apnea: Impact of Modulation of Body Fat, Ectopic Fat, Autonomic Nervous Activity, Inflammatory and Adipokine Profiles. OBES SURG 27, 3156–3164 (2017). https://doi.org/10.1007/s11695-017-2737-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-2737-z